Evaluation of dose reduction versus standard dosing for maintenance of remission in patients with spondyloarthritis and clinical remission with anti-TNF (REDES-TNF): study protocol for a randomized controlled trial.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/20950

Title:	Evaluation of dose reduction versus standard dosing for maintenance of remission in patients with spondyloarthritis and clinical remission with anti-TNF (REDES-TNF): study protocol for a randomized controlled trial.
Authors:	Pontes, Caridad Gratacós, Jordi Torres, Ferran Avendaño, Cristina Sanz, Jesús Vallano, Antoni Juanola, Xavier de Miguel, Eugenio Sanmartí, Raimon Calvo, Gonzalo View more
Mesh:	Anti-Inflammatory Agents Biological Products Biomechanical Phenomena Clinical Protocols Decision Support Techniques Drug Administration Schedule Humans Prospective Studies Recovery of Function Remission Induction Research Design Spain Spine Spondylarthritis Time Factors Treatment Outcome Tumor Necrosis Factor-alpha View more
Issue Date:	20-Aug-2015
Citation:	Trials.2015 Aug;(16):370
Abstract:	Dose reduction schedules of tumor necrosis factor antagonists (anti-TNF) as maintenance therapy in patients with spondyloarthritis are used empirically in clinical practice, despite the lack of clinical trials providing evidence for this practice.
PMID:	26289076
URI:	https://hdl.handle.net/20.500.12530/20950
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos

Files in This Item:

File	Description	Size	Format
PMC4546086.pdf		694.27 kB	Adobe PDF	View/Open